Skip to main content
. 2023 Dec 14;28:590. doi: 10.1186/s40001-023-01576-8

Fig. 2.

Fig. 2

The expression level of ACBD3 in different tumors and normal tissues (*p < 0.05, **p < 0.01, ***p < 0.001) and corresponding immunohistochemistry images. A ACBD3 expression was statistically upregulated in breast invasive carcinoma (BRCA), B ACBD3 expression was statistically upregulated in liver hepatocellular carcinoma (LIHC), C ACBD3 expression was statistically upregulated in lung adenocarcinoma (LUAD), D ACBD3 expression was statistically downregulated in kidney chromophobe (KICH)